Planning multi-arm screening studies within the context of a drug development program
暂无分享,去创建一个
[1] Frank Bretz,et al. Comparison of Methods for the Computation of Multivariate t Probabilities , 2002 .
[2] Thomas Jaki,et al. Optimal design of multi‐arm multi‐stage trials , 2012, Statistics in medicine.
[3] Richard Simon,et al. Two-stage selection and testing designs for comparative clinical trials , 1988 .
[4] Patrick Royston,et al. Novel designs for multi‐arm clinical trials with survival outcomes with an application in ovarian cancer , 2003, Statistics in medicine.
[5] P F Thall,et al. A two-stage design for choosing among several experimental treatments and a control in clinical trials. , 1989, Biometrics.
[6] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[7] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[8] KyungMann Kim. Group Sequential Methods with Applications to Clinical Trials , 2001 .
[9] Gernot Wassmer,et al. On Sample Size Determination in Multi-Armed Confirmatory Adaptive Designs , 2011, Journal of biopharmaceutical statistics.
[10] Martin Posch,et al. Testing and estimation in flexible group sequential designs with adaptive treatment selection , 2005, Statistics in medicine.
[11] J. Wason,et al. Optimal multistage designs for randomised clinical trials with continuous outcomes , 2011, Statistics in medicine.
[12] J. Whitehead,et al. A generalized Dunnett Test for Multi-arm Multi-stage Clinical Studies with Treatment Selection , 2012 .
[13] Frank Bretz,et al. Adaptive designs for confirmatory clinical trials , 2009, Statistics in medicine.
[14] Tim Friede,et al. A group‐sequential design for clinical trials with treatment selection , 2008, Statistics in medicine.
[15] Steven A. Julious,et al. Sample size of 12 per group rule of thumb for a pilot study , 2005 .
[16] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[17] M. Hoelscher,et al. Innovative trial designs are practical solutions for improving the treatment of tuberculosis. , 2012, The Journal of infectious diseases.
[18] J Whitehead,et al. Designing phase II studies in the context of a programme of clinical research. , 1985, Biometrics.
[19] J Whitehead,et al. Sample sizes for phase II and phase III clinical trials: an integrated approach. , 1986, Statistics in medicine.
[20] Tim Friede,et al. A Comparison of Methods for Adaptive Treatment Selection , 2008, Biometrical journal. Biometrische Zeitschrift.
[21] M. Parmar,et al. Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial , 2009, Trials.
[22] Nigel Stallard,et al. Optimal sample sizes for phase II clinical trials and pilot studies , 2012, Statistics in medicine.
[23] D. Bloch,et al. Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. , 2005, Addiction.
[24] J Whitehead,et al. Group sequential clinical trials with triangular continuation regions. , 1983, Biometrics.